Rheumatology clinical trials recruiting in Texas

98 recruiting rheumatology trials match in Texas. Showing 20.

• A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic PainRecruiting

  Phase 2 · Eli Lilly and Company · Austin, Texas

• Safety and Efficacy of ABP-745 in Participants With an Acute Gout FlareRecruiting

  Phase 2 · Atom Therapeutics Co., Ltd · Peoria, Arizona

• A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)Recruiting

  Phase 1 / Phase 2 · Nkarta, Inc. · Dallas, Texas

• The Myelin Disorders Biorepository ProjectRecruiting

  N/A · Children's Hospital of Philadelphia · Houston, Texas

• A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)Recruiting

  Phase 2 · Novartis Pharmaceuticals · Houston, Texas

• CBD for Pain Following Orthopedic Shoulder SurgeryRecruiting

  Phase 1 / Phase 2 · The Methodist Hospital Research Institute · Houston, Texas

• A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled GoutRecruiting

  Phase 3 · Amgen · Dallas, Texas

• A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic ArthritisRecruiting

  Phase 3 · Janssen Research & Development, LLC · Dallas, Texas

• A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)Recruiting

  Phase 3 · Amgen · Baytown, Texas

• AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.Recruiting

  Phase 2 · Artiva Biotherapeutics, Inc. · Arlington, Texas

• A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)Recruiting

  Phase 2 · Protalix · Houston, Texas

• A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the KneeRecruiting

  Phase 3 · Eli Lilly and Company · Dallas, Texas

• An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric ParticipantsRecruiting

  Phase 3 · AstraZeneca · El Paso, Texas

• A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic ArthritisRecruiting

  Phase 3 · Bristol-Myers Squibb · Fortaleza, Ceará

• A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic DiseaseRecruiting

  Phase 3 · EMD Serono Research & Development Institute, Inc. · Allen, Texas

• Guselkumab vs Golimumab in PsA TNF Inadequate Responder PatientsRecruiting

  Phase 3 · University of Pennsylvania · Colleyville, Texas

• The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) StudyRecruiting

  Phase 2 · Children's Hospital Medical Center, Cincinnati · Houston, Texas

• Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Recruiting

  Phase 2 · Merck Sharp & Dohme LLC · Houston, Texas

• A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus ErythematosusRecruiting

  Phase 3 · UCB Biopharma SRL · Bellaire, Texas

• Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus NephritisRecruiting

  Phase 1 · Regeneron Pharmaceuticals · Houston, Texas

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.